|Description||A tumour marker. Only useful in the follow-up of known Ca breast|
|Indication||Predicts recurrence of disease and evaluates response to therapy in a variety of cancers
|Additional Info||Clinical sensitivity ONLY 60%, specificity 87%, positive predictive value 0.91. Test most useful in conjunction with CEA. CA 15.3 is a glycoprotein at apical side of alveoli and in ducts of mammary glands. PLEASE NOTE: TEST CAN ONLY BE ADDED TO A SAMPLE WITHIN 8 HOURS OF COLLECTION|
|Interpretation||Raised in 80% of women with metastatic breast cancer.
|Collection Conditions||No restrictions
|Min. Vol||2 mL|
|Ref. Range (Male)||<30|
|Ref. Range (Female)||<30|
|Ref. Range (Paed)|| |
|Ref. Range Notes||
|IP Acute TAT||Refer to Website|
|IP Routine TAT||Refer to Website|
|GP Acute TAT||- Contact Laboratory|
|GP Routine TAT||Refer to Website|
Originally edited by : JHB. Review due on 23/05/2017 08:01:13. Published By Sylvia McLellan on 23/05/2016 08:01:13.